Skip to main content
Since 1995, the outlook for patients with HIV infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.

HIV Integrase Inhibitors Show Potent Activity in Clinical Trials

Since 1995, the outlook for patients with HIV infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.